http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cdea6106045f84096af0e3a5c5391fc
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Kunz |
| name | Arthur Kunz |
| given-name | Arthur |
| organization-name | Authors' Affiliations: 1Oncology Research Unit, Pfizer Inc., Pearl River, New York; 2Department of Pathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas; and 3Global Biotherapeutic Technologies, Pfizer Inc., Cambridge, Massachusetts Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965 2Wyeth Discovery Chemical and Screening Sciences, Pearl River, New York 2Chemical and Screening Sciences, Wyeth Research, Pearl River New York; and From the Departments of Inflammation, Wyeth Vaccines, Chemical & Screening Sciences, Investigative Pathology, and Oncology Discovery, Wyeth Research, Cambridge, MA Regeneron Pharmaceuticals, Tarrytown, New York. Regeneron Pharmaceuticals, Inc., Tarrytown, New York. From the Departments of Oncology Discovery, Chemical Sciences, Drug Metabolism, and Bioprocess Development, Wyeth Research, Pearl River, NY; and the Department of Research and Development, Celltech, Slough, United Kingdom. |
Incoming Links
Total number of triples: 29.